Concepedia

Shu Fu

SF

6

Publications

192

Citations

6

H-Index

2012

Active since

Affiliations

Zunyi Medical University(Current)

Shu Fu is an author at Zunyi Medical University specializing in medicine, pharmacology, and cardiovascular pharmacology.

Top concepts

MedicinePharmacologyCardiologyPhysiologyCell BiologyHypertensionTumor BiologyCell SignalingVascular BiologyCardiovascular Pharmacology

Publications per year

2012–2019

6

Publications

6

Icariside II attenuates myocardial fibrosis by inhibiting nuclear factor-κB and the TGF-β1/Smad2 signalling pathway in spontaneously hypertensive rats

Shu Fu, Yeli Li, Yuting Wu et al. · Biomedicine & Pharmacotherapy · 2018 · 43 citations

Inflammation, Hypertension, Fibrosis +10

Dehydrocorydaline Inhibits Breast Cancer Cells Proliferation by Inducing Apoptosis in MCF-7 Cells

Zengtao Xu, Xiuping Chen, Shu Fu et al. · The American Journal of Chinese Medicine · 2012 · 42 citations

Breast Oncology, Chemoprevention Strategy, Apoptosis +17

Osthole inhibits cell proliferation by regulating the TGF-β1/Smad/p38 signaling pathways in pulmonary arterial smooth muscle cells

Yun Yue, Yiqi Li, Shu Fu et al. · Biomedicine & Pharmacotherapy · 2019 · 37 citations · Full text

Tgf-β1/smad/p38 Signaling Pathways, Cellular Physiology, Tumor Biology +19

IcarisideII improves left ventricular remodeling in spontaneously hypertensive rats by inhibiting the ASK1-JNK/p38 signaling pathway

Yuting Wu, Zhiqiang Qian, Shu Fu et al. · European Journal of Pharmacology · 2017 · 29 citations

Hypertension, Heart Failure, Cardiomyopathy +11

Icariside II improves myocardial fibrosis in spontaneously hypertensive rats by inhibiting collagen synthesis

Shu Fu, Yeli Li, Yuting Wu et al. · Journal of Pharmacy and Pharmacology · 2019 · 24 citations

Rows per page

1–5 of 6